FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
SAN CLEMENTE, Calif., March 27, 2017 -- David Steenblock, D.O., an osteopathic physician based in San Clemente, CA, uses hyperbaric oxygen to achieve significant and improved lifestyle outcomes for many stroke patients. He is one of the country’s leading practitioners in the therapeutic use of oxygen under pressure to dramatically reduce the effects of stroke and brain injury.
“Many of our cases have demonstrated a 40-100 percent rate of improvement for stroke victims who received oxygen under pressure, “ says Dr. Steenblock. He encourages U.S. physicians to consider the merits of this approach.
Dr. Steenblock treated a 62-year old patient with a stroke that completely paralyzed her right arm and left her severally bent over and limping, He prescribed his patient a series of 60 treatments--within 12 weeks--in a hyperbaric oxygen chamber. Increasing a person’s level of dissolved oxygen using HBOT can activate neuroplasticity and improve stroke-induced neurologic deficiencies, he added.
The goal is to get as much oxygen into the brain as possible. This helps to revive oxygen-starved, damaged brain tissue, Dr. Steenblock explains. This principle holds true for traumatic brain injury as well, where brain tissue is irreversibly destroyed, as brain cells deprived of oxygen usually die within 10 minutes, but a larger portion is potentially revivable.
After one month of treatment, the patient showed clear signs of improvement, with walking, posture and range of motion noticeably improved. She was able to open and close her right hand, grip and squeeze objects, and raise her arm to her chest.
Dr. David Steenblock is a leading-edge physician in many fields of medicine, from stroke care, to acute brain trauma, to generative and cell-based medicine in the treatment of ALS, Cerebral Palsy and other chronic and degenerative diseases. For more information about Dr. Steenblock’s work in stroke therapy, visit www.stemcellmd.org
Irene Doti [email protected]
